More NewsRead More
Chinese FDA Accepts Phase 2 IND for RGN-259 for Dry Eye
June 23, 2014
RegeneRx Receives $1.35 Million Pursuant to Product License And Stock Purchase Agreement
March 28, 2014
RegeneRx Receives Israeli Patent for Treatment of Dry Eye Syndrome
February 24, 2014
RegeneRx Receives Notice of Allowance from U.S. Patent Office for Treatment and Prevention of Neuro and Muscular Degenerative Diseases
January 16, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here